Susceptibility testing of Aspergillus niger strains isolated from poultry to antifungal drugs - a comparative study of the disk diffusion, broth microdilution (M 38-A) and Etest methods

• Autorzy: Tokarzewski S. , Ziolkowska G. , Nowakiewicz A.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to determine the sensitivity of Aspergillus niger strains isolated from birds to available antifungal drugs using different in vitro assays - classical disk diffusion, Etest® and broth microdilution NCCLS/CLSI M 38-A. The study material consisted of about 2.000 swabs and samples from different species of birds. A. niger (n=10) was accounted for 6.81% of the total pool of strains isolated. Determinations were made for 13 antifungal drugs using the disk diffusion method. The A. niger exhibited high susceptibility to enilconazole, terbinafine, voriconazole, tioconazole and ketoconazole, low susceptibility to clotrimazole, miconazole and nystatin, and resistance to amphotericin B, itraconazole, pimaricin, fluconazole and 5-fluorocytosine. Minimum inhibitory concentration (MIC) was determined for 9 antifungal drugs using the micromethod of duplicate serial dilutions in a liquid medium. A. niger strains were most susceptible to enilconazole and voriconazole. MIC ranged from 0.0625 to 0.5 μg/ml for enilconazole, with MIC90-0.5 μg/ml and MIC50-0.125 μg/ml. The corresponding values for voriconazole were 0.25-1 μg/ml, 1 μg/ml and 0.5 μg/ml. MIC for amphotericin B and terbinafine ranged from 0.5 to 4 μg/ml, while the values for the remaining drugs were highly varied. MIC was measured by the gradient diffusion method using Etest® for 5 antifungal drugs: amphotericin B, fluconazole, itraconazole, ketoconazole and voriconazole. By far the highest susceptibility was obtained in the case of voriconazole, with MIC ranging from 0.0625 to 1 μg/ml. MIC for amphotericin B ranged from 0.25 to 4 μg/ml, for itraconazole and ketoconazole ranging from 0.5 to 16 μg/ml. Methods available for this purpose are not always applicable in field conditions. The present results indicate that the Etest® technique, due to its high percentage of agreement with the M 38-A microdilution method, should find application in medical and veterinary practice.

Słowa kluczowe

EN

susceptibility; Aspergillus niger; isolation; poultry; antifungal drug; disk diffusion; broth microdilution method; disc-diffusion method; Etest procedure; aspergillosis; fungal infection; respiratory tract

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2012
• Tom: 15
• Numer: 1
• Opis fizyczny: p.125-133,fig.,ref.

Twórcy

autor

Tokarzewski S.

• Sub-Department of Veterinary Microbiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Akademicka 12, 20-033 Lublin, Poland

autor

Ziolkowska G.

autor

Nowakiewicz A.

Bibliografia

• Akan M, Haziroglu R, Ilhan Z, Sareyyupoglu B, Tunca R (2002) A case of aspergillosis in a broiler breeder flock. Avian Dis 46: 497-501.
• Araujo R, Pina-Vaz C, Rodrigues AG (2007) Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int J Antimicrob Agents 29: 108-111.
• Buchta V, Vejsova M, Vale-Silva LA (2008) Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing. Folia Microbiol 53: 153-160.
• Chen SC, O’Donnell ML, Gordon S, Gilbert GL (1996) Antifungal susceptibility testing using the Etest: comparison with the broth macrodilution technique. J Antimicrob Chemother 37: 265-273.
• National Committee for Clinical Laboratory Standards. (2002) Method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. NCCLS document M38-A. Clinical and Laboratory Standards Institute. Wayne, PA.
• National Committee for Clinical Laboratory Standards. (2004) Reference method for antifungal disc diffusion susceptibility testing of yeasts. Approved standard, 2nd ed. NCCLS document M44-A. Clinical Laboratory Standards Institute. Wayne, PA.
• Colombo AL, Barchiesi F, McGough DA, Rinaldi MG (1995) Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 33: 535-540.
• De Hoog GS, Guarro J, Gene J, Figueras MJ (2000) Atlas of clinical fungi. 2nd ed., Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands and Universitat Rovera and Virgili, Reus, Spain,
• Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW (1997a) Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 40: 401-414.
• Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, Warnock DW, Kelly SL (1997b) Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 41: 1364-1368.
• Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL, Wang A (2007) Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol 45: 1811-1820.
• Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, Rinaldi M, Walsh TJ (2001) Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob Agents Chemother 45: 1828-1835.
• Espinel-Ingroff A, Johnson E, Hockey H, Troke P (2008) Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J Antimicrob Chemother 61: 616-620.
• Espinel-Ingroff A, Rezusta A (2002) E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posakonazole and to established antifungal agents: comparison with NCCLS broth microdilution mehod. J Clin Microbiol 40: 2101-2107.
• Espinel-Ingroff A (2007) Standardized disk diffusion method for yeasts. Clin Microbiol Newsletter 29: 97-100.
• Flammer K, Nettifee Osborne JA, Webb DJ, Foster LE, Dillard SL, Davis JL (2008) Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh). Am J Vet Res 69: 114-121.
• Guinea J, Pelaez T, Alcala L, Bouza E (2007) Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis 57: 273-276.
• Khosravi AR, Shokri H, Ziglari T, Naeini AR, Mousavi Z, Hashemi H (2008) Outbreak of severe disseminated aspergillosis in a flock of ostrich (Struthio camelus). Mycoses 51: 557-559.
• Lass-Flörl C, Kofler G, Kropshofer G, Hermans J, Kreczy A, Dierich MP, Niederwieser D (1998) In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42: 497-502.
• Martin MP, Bouck KP, Helm J, Dykstra MJ, Wages DP, Barnes HJ (2007) Disseminated Aspergillus flavus infection in broiler breeder pullets. Avian Dis 51: 626-631.
• Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E (2003) Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrobial Chemotherapy 52: 365-370.
• Mendez CC, Serrano MC, Valverde A, Peman J, Almeida C, Martin-Mazuelos E (2008) Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes. Med Mycol 46: 119-123.
• Pfaller MA, Messer SA, Boyken L, Hollis RJ, Diekema DJ (2003a) In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagn Microbiol Infect Dis 45: 241-244.
• Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA (2003b) In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol 41: 1126-1129.
• Pfaller MA, Messer SA, Mills K, Bolmstrom A (2000) In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol 38: 3359-3361.
• Schuster E, Dunn-Coleman N, Frisvad JC, van Dijck PW (2002) On the safety of Aspergillus niger – a review. Appl Microbiol Biotechnol 59: 426-435.
• Silvanose CD, Bailey TA, Di Somma A (2006) Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole. Vet Rec 159: 282-284.
• Szekely A, Johnson EM, Warnock DW (1999) Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 37: 1480-1483.
• Tokarzewski S, Ziółkowska G, Łopuszyński W, Nozdryn-Płotnicki Z (2007) Aspergillus fumigatus infection in a pigeon flock. Bull Vet Inst Pulawy 51: 563-567.
• Van Cutsem J (1983) Antifungal activity of enilconazole on experimental Aspergillosis in chickens. Avian Dis 27: 36-42.
• Ziółkowska G, Tokarzewski S, Nowakiewicz A (2010) Aspergillus genus – species diversifying but the sensitivity to antifungal preparations. Mikol Lek 17: 97-102.
• Ziółkowska G, Tokarzewski S (2007) Occurrence of moulds in reproductive goose flocks in southern-eastern Poland. Bull Vet Inst Pulawy 51: 553-561.
• Ziółkowska G, Tokarzewski S (2006) Determination of antifungal activity of Enizol: a specific disinfecting preparation. Med Weter 62: 792-796.